Mitochondrial Dysfunction Contributes to Impaired Cytokine Production of CD56bright Natural Killer Cells From Human Immunodeficiency Virus-Infected Individuals Under Effective Antiretroviral Therapy

J Infect Dis. 2022 Sep 13;226(5):901-906. doi: 10.1093/infdis/jiac103.

Abstract

Human immunodeficiency virus (HIV) infection is associated with impaired natural killer (NK) cell activity, which is only incompletely restored under antiretroviral therapy. Analyzing the bioenergetics profiles of oxygen consumption, we observed that several parameters were significantly reduced in HIV+ NK cells, indicating a mitochondrial defect. Accordingly, we found HIV+ CD56bright NK cells to display a decreased mitochondrial membrane potential and mitochondrial mass. Both parameters were positively correlated with interferon gamma (IFN-γ) production of NK cells. Finally, we demonstrated that stimulation of HIV+ NK cells with MitoTEMPO, a mitochondria-targeting antioxidant, significantly improved IFN-γ production. We identified mitochondrial dysfunction as a mechanism that contributes to impaired NK cell function.

Keywords: HIV; IFN-γ; NK cell; immunometabolism; mitochondrial dysfunction.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • CD56 Antigen / metabolism
  • Cytokines / metabolism
  • HIV / metabolism
  • HIV Infections* / complications
  • Humans
  • Killer Cells, Natural / metabolism
  • Mitochondria / metabolism

Substances

  • CD56 Antigen
  • Cytokines